Статья
Магнитно-резонансная томография сердца с контрастированием при интервенционном лечении фибрилляции предсердий
Катетерная аблация на сегодняшний день является основным методом интервенционного лечения фибрилляции предсердий (ФП). Несмотря на совершенствование методики и накопление опыта выполняющего вмешательства персонала, частота рецидивов ФП после катетерных вмешательств по-прежнему остается высокой. В обзоре рассмотрены возможности применения магнитно-резонансной томографии сердца с контрастированием с целью повышения эффективности интервенционного лечения аритмии.
1. Revishvili A.Sh., Shlyakhto E.V., Sulimov V.A., Rzaev F.G., Gorev M.V., Nardaya Sh.G. et al. Recommendations RKO, VNOA and ASSH ‘Diagnosis and treatment of atrial fibrillation’ 2017. 211p. 2017.
2. Akramova E.G. Characteristic of cardiac rhythm disturbances in patients with chronic obstructive pulmonary disease. Clinical medicine. 2013;91(2):41–4.
3. Shcherbakova N.V., Meshkov A.N., Boytsov S.A. Exome sequencing and the diagnostics of complex disease predisposition in preventive medicine. Cardiovascular Therapy and Prevention. 2013;12(6):24–8.
4. Kostyukevich M.V., Zykov K.A., Mironova N.A., Agapova O.Yu., Shevelev A.Ya., Efremov E.E. et al. Role of Autoantibodies Against ßj-Adrenergic Receptor in Cardiovascular Disease. Kardiologiia. 2016;56(12):82–91.
5. Ball J, Carrington MJ, McMurray JJV, Stewart S. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century. International Journal of Cardiology. 2013;167(5):1807–24. DOI: 10.1016/j.ijcard.2012.12.093
6. Yakovenko T.V., Shubik Yu.V., Kostyuk G.P., Kryatova T.V. Quality of life of patients with different types of arial fibrillation and effect of treatment of nosogenic psychic disorders. Journal of Arrhythmology. 2008; 51:36–9.
7. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener H-C et al. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). European Heart Journal. 2007;28(22):2803–17. DOI: 10.1093/eurheartj/ehm358
8. Yuricheva Yu.A., Maykov E.B., Sokolov S.F., Mironov N.Yu., Klimenko Yu.L., Kratskina T.L. et al. Efficacy and safety of a new class III antiarrhythmic drug niferidil in relieving persistent forms of atrial fibrillation and flutter. Kardiologicheskij Vestnik. 2011;6(1):5–15.
9. Mironov N.Yu., Vlodzyanovskiy V.V., Yuricheva Yu.A., Sokolov S.F., Golitsyn S.P., Rosenstraukh L.V. et al. Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness. Rational Pharmacotherapy in Cardiology. 2018;14(5):664–9.. DOI: 10.20996/1819-6446-2018-14-5-664-669
10. Novikov I.A., Mironov N.Yu., Maykov E.B., Kovalenko A.S. Advances of balloon cryoablation for treatment of atrial fibrillation. Kardiologicheskii vestnik. 2018;13(3):10–5.. DOI: 10.17116/Cardiobulletin20181303110
11. Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275–444. DOI: 10.1016/j.hrthm.2017.05.012
12. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines on management of atrial fibrillation developedin collaboration with EACTS. Russian Journal of Cardiology. 2017;22(7):7–86.. DOI: 10.15829/1560-4071-2017-7-7-86
13. Kottkamp H, Bender R, Berg J. Catheter Ablation of Atrial Fibrillation. Journal of the American College of Cardiology. 2015;65(2):196–206. DOI: 10.1016/j.jacc.2014.10.034
14. Krueger MW, Dorn A, Keller DUJ, Holmqvist F, Carlson J, Platonov PG et al. In-silico modeling of atrial repolarization in normal and atrial fibrillation remodeled state. Medical & Biological Engineering & Computing. 2013;51(10):1105–19. DOI: 10.1007/s11517-013-1090-1
15. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F et al. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation: The DECAAF Study. JAMA. 2014;311(5):498–506. DOI: 10.1001/jama.2014.3
16. Aparina O.P., Chikhireva L.N., Stukalova O.V., Mironova N.A., Kashtanova S.Yu., Ternovoy S.K. et al. Atrial Fibrillation as Consequence and Cause of Structural Changes of Atria. Kardiologiia. 2014;54(11):57–64.
17. Spach MS, Boineau JP. Microfibrosis Produces Electrical Load Variations Due to Loss of Side-to-Side Cell Connections; A Major Mechanism of Structural Heart Disease Arrhythmias. Pacing and Clinical Electrophysiology. 1997;20(2):397–413. DOI: 10.1111/j.1540-8159.1997.tb06199.x
18. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH et al. Paroxysmal Lone Atrial Fibrillation Is Associated With an Abnormal Atrial Substrate. Journal of the American College of Cardiology. 2009;53(14):1182–91. DOI: 10.1016/j.jacc.2008.11.054
19. Krueger MW, Rhode KS, O‘Neill MD, Rinaldi CA, Gill J, Razavi R et al. Patient-specific modeling of atrial fibrosis increases the accuracy of sinus rhythm simulations and may explain maintenance of atrial fibrillation. Journal of Electrocardiology. 2014;47(3):324–8. DOI: 10.1016/j.jelectrocard.2013.11.003
20. Higuchi K, Akkaya M, Akoum N, Marrouche NF. Cardiac MRI assessment of atrial fibrosis in atrial fibrillation: implications for diagnosis and therapy. Heart. 2014;100(7):590–6. DOI: 10.1136/heartjnl-2013-303884
21. Narayan SM, Baykaner T, Clopton P, Schricker A, Lalani GG, Krummen DE et al. Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Aloneextended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation). Journal of the American College of Cardiology. 2014;63(17):1761–8. DOI: 10.1016/j.jacc.2014.02.543
22. Lin Y-J, Lo M-T, Lin C, Chang S-L, Lo L-W, Hu Y-F et al. Prevalence, Characteristics, Mapping, and Catheter Ablation of Potential Rotors in Nonparoxysmal Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2013;6(5):851–8. DOI: 10.1161/CIRCEP.113.000318
23. Verma A, Jiang C, Betts TR, Chen J, Deisenhofer I, Mantovan R et al. Approaches to Catheter Ablation for Persistent Atrial Fibrillation. New England Journal of Medicine. 2015;372(19):1812–22. DOI: 10.1056/NEJMoa1408288
24. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C et al. Evaluation of Techniques for the Quantification of Myocardial Scar of Differing Etiology Using Cardiac Magnetic Resonance. JACC: Cardiovascular Imaging. 2011;4(2):150–6. DOI: 10.1016/j.jcmg.2010.11.015
25. Stukalova O.V., Gupalo E.M., Mironova N.A., Egiazaryan L.G., Utsumueva M.D. Role of contrast-enhanced cardiac MRI in diagnosing myocarditis with different clinical courses. Russian Heart Journal. 2016;15(2):133–40.. DOI: 10.18087/rhj.2016.2.2171
26. Stukalova O.V., Mironova N.A., Utsumueva M.D., Kashtanova S. Yu., Malkina T.A., Golitsyn S.P. et al. Method for determining severity of fibrous myocardial damage using mrt for selecting candidates for cardiac resynchronising therapy. Patent RU 2685643С1.
27. Utsumueva M.D., Mironova N.A., Kashtanova S.Yu., Stukalova O.V. Possibilities of cardiac magnetic resonance in selection of candidates for cardiac resynchronization therapy. Medical Visualization. 2018;22(4):20–31.. DOI: 10.24835/1607-0763-2018-4-20-31
28. Croisille P, Revel D, Saeed M. Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside. European Radiology. 2006;16(9):1951–63. DOI: 10.1007/s00330-006-0244-z
29. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN et al. Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation. Circulation. 2009;119(13):1758–67. DOI: 10.1161/CIRCULATIONAHA.108.811877
30. Karim R, Arujuna A, Brazier A, Gill J, Rinaldi CA, O’Neill M et al. Automatic Segmentation of Left Atrial Scar from Delayed-Enhancement Magnetic Resonance Imaging. In: Functional Imaging and Modeling of the Heart Metaxas DN, Axel L, editors -Berlin, Heidelberg: Springer Berlin Heidelberg;2011.
31. Karim R, Housden RJ, Balasubramaniam M, Chen Z, Perry D, Uddin A et al. Evaluation of current algorithms for segmentation of scar tissue from late Gadolinium enhancement cardiovascular magnetic resonance of the left atrium: an open-access grand challenge. Journal of Cardiovascular Magnetic Resonance. 2013;15(1):105. DOI: 10.1186/1532-429X-15-105
32. Spragg DD, Khurram I, Zimmerman SL, Yarmohammadi H, Barcelon B, Needleman M et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: Success and limitations. Heart Rhythm. 2012;9(12):2003–9. DOI: 10.1016/j.hrthm.2012.08.039
33. Malcolme-Lawes LC, Juli C, Karim R, Bai W, Quest R, Lim PB et al. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: A 2-center study. Heart Rhythm. 2013;10(8):1184–91. DOI: 10.1016/j.hrthm.2013.04.030
34. Aparina O.P., Stukalova O.V., Parkhomenko D.V., Mironova N.A., Butorova E.A., Bolotova M.N. et al. Characteristics of left atrial myocardium structure in tarial fibrillation and healthy volunteers according to late gadolinium enhancement magnetic resonanse imaging. Journal of Arrhythmology. 2014;77:5–12.
35. Aparina O.P., Stukalova O.V., Parkhomenko D.V., Mironova N.A., Strazdenj E.Yu., Ternovoy S.K. et al. Structural and Functional Properties of the Left Atrium in Healthy Volunteers and Patients With Atrial Fibrillation: Data of Magnetic Resonance Imaging. Kardiologiia. 2017;57(9):5–13.. DOI: 10.18087/cardio.2017.9.10029
36. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S et al. Left Atrial Strain and Strain Rate in Patients With Paroxysmal and Persistent Atrial Fibrillation: Relationship to Left Atrial Structural Remodeling Detected by Delayed-Enhancement MRI. Circulation: Cardiovascular Imaging. 2010;3(3):231–9. DOI: 10.1161/CIRCIMAGING.109.865683
37. Akkaya M, Higuchi K, Koopmann M, Burgon N, Erdogan E, Damal K et al. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation. Europace. 2013;15(12):1725–32. DOI: 10.1093/europace/eut147
38. Beinart R, Khurram IM, Liu S, Yarmohammadi H, Halperin HR, Bluemke DA et al. Cardiac magnetic resonance T1 mapping of left atrial myocardium. Heart Rhythm. 2013;10(9):1325–31. DOI: 10.1016/j.hrthm.2013.05.003
39. Ling L, McLellan AJA, Taylor AJ, Iles LM, Ellims AH, Kumar S et al. Magnetic resonance post-contrast T1 mapping in the human atrium: Validation and impact on clinical outcome after catheter ablation for atrial fibrillation. Heart Rhythm. 2014;11(9):1551–9. DOI: 10.1016/j.hrthm.2014.06.012
40. Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: Implications for disease progression and response to catheter ablation. Heart Rhythm. 2010;7(10):1475–81. DOI: 10.1016/j.hrthm.2010.06.030
41. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K et al. Atrial Fibrillation Ablation Outcome Is Predicted by Left Atrial Remodeling on MRI. Circulation: Arrhythmia and Electrophysiology. 2014;7(1):23–30. DOI: 10.1161/CIRCEP.113.000689
42. Akoum N, Daccarett M, Mcgann C, Segerson N, Vergara G, Kuppahally S et al. Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach. Journal of Cardiovascular Electrophysiology. 2011;22(1):16–22. DOI: 10.1111/j.1540-8167.2010.01876.x
43. Peters DC, Wylie JV, Hauser TH, Nezafat R, Han Y, Woo JJ et al. Recurrence of Atrial Fibrillation Correlates With the Extent of Post-Procedural Late Gadolinium Enhancement. JACC: Cardiovascular Imaging. 2009;2(3):308–16. DOI: 10.1016/j.jcmg.2008.10.016
44. McGann C, Kholmovski E, Blauer J, Vijayakumar S,
45. Haslam T, Cates J et al. Dark Regions of No-Reflow on Late Gadolinium Enhancement Magnetic Resonance Imaging Result in Scar Formation After Atrial Fibrillation Ablation. Journal of the American College of Cardiology. 2011;58(2):177–85. DOI: 10.1016/j.jacc.2011.04.008
46. Arujuna A, Karim R, Caulfield D, Knowles B, Rhode K, Schaeffter T et al. Acute Pulmonary Vein Isolation Is Achieved by a Combination of Reversible and Irreversible Atrial Injury After Catheter Ablation: Evidence From Magnetic Resonance Imaging. Circulation: Arrhythmia and Electrophysiology. 2012;5(4):691–700. DOI: 10.1161/CIRCEP.111.966523
47. Taclas JE, Nezafat R, Wylie JV, Josephson ME, Hsing J, Manning WJ et al. Relationship between intended sites of RF ablation and post-procedural scar in AF patients, using late gadolinium enhancement cardiovascular magnetic resonance. Heart Rhythm. 2010;7(4):489–96. DOI: 10.1016/j.hrthm.2009.12.007
48. Lichter J, Kholmovski EG, Coulombe N, Ghafoori E, Kamali R, MacLeod R et al. Real-time magnetic resonance imaging-guided cryoablation of the pulmonary veins with acute freeze-zone and chronic lesion assessment. EP Europace. 2019;21(1):154–62. DOI: 10.1093/europace/euy089
49. Saeed I, Soltys JS, Gupta S, Longmore R. Post ablation timing to best visualize left-atrial Llesions: a feasibility study. Journal of Cardiovascular Magnetic Resonance. 2016;18(S1):P203. DOI: 10.1186/1532-429X-18-S1-P203
50. Hunter RJ, Jones DA, Boubertakh R, Malcolme-Lawes LC, Kanagaratnam P, Juli CF et al. Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Detection and Characterization of Left Atrial Catheter Ablation Lesions: A Multicenter Experience. Journal of Cardiovascular Electrophysiology. 2013;24(4):396–403. DOI: 10.1111/jce.12063
51. Bokeria L.A., Bazaev V.A., Filatov A.G., Bokeria O.L., Melikulov A Kh., Viskov R.V. et al. Endocardial mapping for catheter radiofrequency ablation in patients with atrial fibrillation. Annals of Arrhythmology. 2005;2 (3):25–31.